Anti-Nephrin Antibodies in Minimal Change Disease
Approach to the Patient with Peritoneal Dialysis Catheter Dysfunction- Part 1
Want to write a case report? RFN has you covered with a list of journals to choose from
Have a Nephrology Question? There Might Be A #Tweetorial For That!
Conferences, Courses, & Grants
FOAMed
Interventional Nephrology Series
Focus on Point-of-Care Ultrasound in Nephrology (POCUN) Series
Kidney Biopsy of the Month Series
atheroembolic renal disease
I heard a lecture not too long ago on atheroembolic renal disease which claimed that atheroembolic renal disease is to nephrology as sarcoidosis is to internal medicine. That is to say, it can present in a myriad of…
Reticular Inclusions in HIVAN
The histology of HIVAN (HIV-Associated Nephropathy), at the light microscopy level, is indistinguishable from that of collapsing FSGS: the glomerular capillary loops are collapsed. Furthermore, both entities demonstrate foot process effacement (as in all forms of nephrotic syndrome)…
MMF Basics
Mycophenolic acid is a commonly encountered medication in nephrology. In addition to its use in the vast majority of kidney transplant recipients as part of the immunosuppressive regimen, it is also gaining popularity in the treatment of immune-mediated…
Rituxan for Membranous Nephropathy?
Clinical trials evaluating the efficacy of various therapies of membranous nephropathy is a tricky business, given the natural history of the disease: because about 1/3 of patients spontaneously remit, it is often difficult to say that a patient’s…
By the Numbers: Dialysis Providers
This is an interesting figure, taken from the 2008 USRDS (United States Renal Disease System) Atlas, which illustrates where patients in the U.S. are getting their dialysis from these days. Nearly 63% of all patients are getting dialysis…
How much Cytoxan is too much?
Cytoxan is a very potent but also potentially toxic medication used for a variety of immune-mediated (and nephrology-relevant) diseases. It is often classified as a “cytotoxic agent”, as it works as an alkylating agent that explains its utility…
More Negative Statin Data in ESRD Patients
HMG coA-reductase inhibitors (a.k.a. “statins”) are one of the most successful drugs in recent history…one does not have to look far to find good, solid randomized, controlled trials touting the benefits of statin therapy in any number of…
Albuminuria Screening for the General Population?
An article by van de Velde et al in this month’s JASN describes the results of the Prevention of Renal and Vascular End-stage Disease (PREVEND) study, a cohort study in which the ability to predict the need for…
Is Kt/V really the best way to measure dialysis adequacy?
This morning’s Renal Grand Rounds was an interesting talk given by Edmund Lowrie, a nephrologist currently employed by Fresenius Dialysis who has been studying measurements of dialysis adequacy for several decades. In his talk, he made the case…
The Polypill
This week’s Lancet has an interesting article from The Indian Polycap Study (TIPS), in which investigators tested the efficacy and tolerability of a single pill containing up to FIVE different cardiovascular medications: a beta-blocker, an ACE-inhibitor, a thiazide…